Vivian de Jong

PHD Candidate - OIO

Contact

Recent publications

Care Pathways for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Kirsi M A van Eekhout, Leonard D Broekman, Vivian D de Jong, Maurice Michel, Rick Grobbee, Douglas Maya-Miles, Manuel Romero-Gómez, Jean Muris, Juan M Mendive, Yasaman Vali, Oscar H Franco, Jörn M Schattenberg, Céline Fournier-Poizat, Manuel Castro Cabezas, Maarten E Tushuizen, Adriaan G Holleboom
Liver International, 2026, vol. 46

Genetic risk factors for MASLD/MASH and cardiovascular disease in elderly individuals Willy B Theel, Vivian D de Jong, Diederick E Grobbee, J Wouter Jukema, Stella Trompet, Manuel Castro Cabezas
Annals of Hepatology, 2025, vol. 31

Liver Fibrosis as a Predictor of Cardiovascular Risk in Patients with Severe Obesity Alina N Saidi, Willy B Theel, Vivian D de Jong, Stefanie R van Mil, Aart-Jan van der Lely, Diederick E Grobbee, Jan Apers, Ellen van der Zwan-van Beek, Manuel Castro Cabezas
Journal of Clinical medicine, 2025, vol. 14

Assessing the effects of naltrexone-bupropion on hepatic steatosis and fibrosis in patients with T2DM and overweight or obesity Alina N Saidi, Laura A M Konings, Carmen A W Dietvorst, Vivian D de Jong, Willem Pieter Brouwer, Aart-Jan van der Lelij, Marco Alings, Martien van Wenum, Simone P Rauh, Weiwei Xu, Manuel Castro Cabezas
Diabetes, Obesity & Metabolism, 2025, vol. 27, p.6624-6631

Reply to Vivian D. de Jong, Stella Trompet, J. Wouter Jukema, Diederick E. Grobbee, Manuel Castro Cabezas
JHEP Reports, 2025, vol. 7

Can targeting de novo lipogenesis improve liver health? Manuel Castro Cabezas, Vivian D de Jong
The Lancet. Gastroenterology & hepatology, 2025, vol. 10, p.873-874